Martin William Dewhurst - 07 Jan 2026 Form 4 Insider Report for Turn Therapeutics Inc. (TTRX)

Reporting relationship: Director
Issuer ticker: TTRX
Reported as of: 07 Jan 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Feb 2026, 07:31:02 UTC
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Zuraiz Chaudhary, attorney-in-fact for Martin William Dewhurst

Key filing fact

Martin William Dewhurst filed Form 4 for Turn Therapeutics Inc. (TTRX) on 04 Feb 2026.

Key facts

This page summarizes Martin William Dewhurst's Form 4 filing for Turn Therapeutics Inc. (TTRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Feb 2026, 07:31.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002108597 Primary reporting owner

Dewhurst Martin William

Relationship: Director
Address: C/O TURN THERAPEUTICS INC., 250 N. WESTLAKE BLVD., WESTLAKE VILLAGE
Signature: /s/ Zuraiz Chaudhary, attorney-in-fact for Martin William Dewhurst
Signature date: 04 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TTRX transaction

Common Stock

Award

Transaction value: $0
Shares: +21,882
Change %
Price: $0.000000
Shares after: 21,882
Date: 07 Jan 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The securities reported in Column 5 of Table I are restricted stock units ("RSU"). Each RSU represents a contingent right to receive one share of common stock, subject to the applicable vesting schedule and conditions of the applicable RSU award and the Issuer's 2025 Omnibus Incentive Plan. The 21,882 RSUs included in Column 5 of Table I vest in full on January 7, 2027, subject to the reporting person's continuous service to the Issuer.